Abstract
Cerebrotendinous xanthomatosis is an exceptionally rare condition in Indian subcontinent, however, it is potentially treatable if diagnosed. We present and discuss the clinical presentation and investigations in a case of cerebrotendinous xanthomatosis (CTX).
MeSH terms
-
Adult
-
Ataxia / etiology*
-
Chenodeoxycholic Acid
-
Cholestanol
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Male
-
Xanthomatosis, Cerebrotendinous / complications*
-
Xanthomatosis, Cerebrotendinous / drug therapy
Substances
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Chenodeoxycholic Acid
-
Cholestanol